ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

January 14, 1994

Rauscher To Become ACS VP For Research Nov. 1; Search Starts for New NCI Director

September 24, 1976

Duke Officials Decline To Provide Details Of Probe

July 23, 2010

Obituaries: Jessie Gruman, 60, CFAH Founder and President; Jesse Leonard Steinfeld, 87, U.S. Surgeon General

September 5, 2014